Published in Annu Rev Clin Psychol on January 01, 2007
Defining comorbidity: implications for understanding health and health services. Ann Fam Med (2009) 5.78
Lifetime psychiatric disorders in school-aged offspring of parents with bipolar disorder: the Pittsburgh Bipolar Offspring study. Arch Gen Psychiatry (2009) 2.40
Routine screening for depression in patients with coronary heart disease never mind. J Am Coll Cardiol (2009) 1.99
Psychiatric disorders in preschool offspring of parents with bipolar disorder: the Pittsburgh Bipolar Offspring Study (BIOS). Am J Psychiatry (2010) 1.81
Comorbid depression and anxiety symptoms as predictors of cardiovascular events: results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. Psychosom Med (2009) 1.70
Diagnostic criteria for depression in type 2 diabetes: a data-driven approach. PLoS One (2014) 1.42
Integrating technology into cognitive behavior therapy for adolescent depression: a pilot study. Ann Gen Psychiatry (2015) 1.41
Testing a social-cognitive model of HIV transmission risk behaviors in HIV-infected MSM with and without depression. Health Psychol (2010) 1.31
Retention in depression treatment among ethnic and racial minority groups in the United States. Depress Anxiety (2010) 1.30
Tailored vs. standardized internet-based cognitive behavior therapy for depression and comorbid symptoms: a randomized controlled trial. PLoS One (2012) 1.23
Relationships between cardiovascular disease risk factors and depressive symptoms as predictors of cardiovascular disease events in women. J Womens Health (Larchmt) (2011) 1.21
Primum non nocere: an evolutionary analysis of whether antidepressants do more harm than good. Front Psychol (2012) 1.20
Understanding locally, culturally, and contextually relevant mental health problems among Rwandan children and adolescents affected by HIV/AIDS. AIDS Care (2011) 1.12
Psychodynamic guided self-help for adult depression through the internet: a randomised controlled trial. PLoS One (2012) 1.08
Depression, anxiety and their comorbidity in the Swedish general population: point prevalence and the effect on health-related quality of life. PeerJ (2013) 1.08
Co-morbid anxiety disorders in bipolar disorder and major depression: familial aggregation and clinical characteristics of co-morbid panic disorder, social phobia, specific phobia and obsessive-compulsive disorder. Psychol Med (2011) 1.03
Web-based therapist training on cognitive behavior therapy for anxiety disorders: a pilot study. Psychotherapy (Chic) (2013) 1.02
Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E₂ concentration in rat brain. J Neurochem (2011) 1.02
Transdermal estradiol for postpartum depression: a promising treatment option. Clin Obstet Gynecol (2009) 1.01
Genetic and environmental influences on psychiatric comorbidity: a systematic review. J Affect Disord (2009) 1.00
Dimensional psychopathology in offspring of parents with bipolar disorder. Bipolar Disord (2011) 0.97
Avatar-based depression self-management technology: promising approach to improve depressive symptoms among young adults. Appl Nurs Res (2012) 0.92
Decline in cardiorespiratory fitness and odds of incident depression. Am J Prev Med (2012) 0.91
Access to adequate outpatient depression care for mothers in the USA: a nationally representative population-based study. J Behav Health Serv Res (2009) 0.91
Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target? Expert Rev Neurother (2012) 0.89
Differentiating bipolar disorder-not otherwise specified and severe mood dysregulation. J Am Acad Child Adolesc Psychiatry (2013) 0.89
Blue again: perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression. Front Psychol (2011) 0.89
DHA deficiency and prefrontal cortex neuropathology in recurrent affective disorders. J Nutr (2010) 0.89
Responding to Anxiety with Rumination and Hopelessness: Mechanism of Anxiety-Depression Symptom Co-Occurrence? Cognit Ther Res (2012) 0.88
The combined effect of norepinephrine transporter gene and negative life events in major depression of Chinese Han population. J Neural Transm (Vienna) (2008) 0.88
Depressive symptoms in people with chronic physical conditions: prevalence and risk factors in a Hong Kong community sample. BMC Psychiatry (2012) 0.87
Membrane omega-3 Fatty Acid deficiency as a preventable risk factor for comorbid coronary heart disease in major depressive disorder. Cardiovasc Psychiatry Neurol (2009) 0.87
NMDA receptor involvement in antidepressant-like effect of pioglitazone in the forced swimming test in mice. Psychopharmacology (Berl) (2012) 0.87
Mental health, substance use and intimate partner problems among pregnant and postpartum suicide victims in the National Violent Death Reporting System. Gen Hosp Psychiatry (2011) 0.86
Treating insomnia improves mood state, sleep, and functioning in bipolar disorder: a pilot randomized controlled trial. J Consult Clin Psychol (2015) 0.85
Rumination prospectively predicts executive functioning impairments in adolescents. J Behav Ther Exp Psychiatry (2013) 0.85
Does managed care affect the diffusion of psychotropic medications? Health Econ (2011) 0.85
Using biomarkers to predict treatment response in major depressive disorder: evidence from past and present studies. Dialogues Clin Neurosci (2014) 0.84
Primary care and behavioral health practice size: the challenge for health care reform. Med Care (2012) 0.84
Temporal patterns of anxious and depressed mood in generalized anxiety disorder: a daily diary study. Behav Res Ther (2011) 0.84
Major depressive disorder following terrorist attacks: a systematic review of prevalence, course and correlates. BMC Psychiatry (2011) 0.83
The Depressive Attributions Questionnaire (DAQ): Development of a Short Self-Report Measure of Depressogenic Attributions. J Psychopathol Behav Assess (2011) 0.82
Major depressive disorder and measures of cellular aging: an integrative review. Nurs Res Pract (2013) 0.82
NMDA receptor/nitrergic system blockage augments antidepressant-like effects of paroxetine in the mouse forced swimming test. Psychopharmacology (Berl) (2009) 0.81
EEG power asymmetry and functional connectivity as a marker of treatment effectiveness in DBS surgery for depression. Neuropsychopharmacology (2013) 0.81
Antidepressant-like cognitive and behavioral effects of acute ketamine administration associated with plasticity in the ventral hippocampus to medial prefrontal cortex pathway. Psychopharmacology (Berl) (2015) 0.81
Bipolar-I depression outpatient treatment quality and costs in usual care practice. Psychopharmacol Bull (2008) 0.81
Adipocytokine signaling is altered in Flinders sensitive line rats, and adiponectin correlates in humans with some symptoms of depression. Pharmacol Biochem Behav (2012) 0.81
Psychiatric comorbidities in patients with major depressive disorder. Neuropsychiatr Dis Treat (2014) 0.81
Negative life events and corticotropin-releasing-hormone receptor1 gene in recurrent major depressive disorder. Sci Rep (2013) 0.81
Interventions for youth at high risk for bipolar disorder and schizophrenia. Child Adolesc Psychiatr Clin N Am (2012) 0.80
Comorbidity of depressive and anxiety disorders: challenges in diagnosis and assessment. Shanghai Arch Psychiatry (2014) 0.79
Predictors of treatment utilization in major depression. Arch Suicide Res (2011) 0.79
Effects, experiences, and impact of stigma on patients with bipolar disorder. Neuropsychiatr Dis Treat (2013) 0.79
Dimensional psychopathology in preschool offspring of parents with bipolar disorder. J Child Psychol Psychiatry (2013) 0.79
The role of hippocampal atrophy in depression: a neurocomputational approach. J Biol Phys (2008) 0.78
Clinical characteristics and long-term response to mood stabilizers in patients with bipolar disorder and different age at onset. Neuropsychiatr Dis Treat (2009) 0.78
One-year treatment outcomes of African-American and Hispanic patients with bipolar I or II disorder in STEP-BD. Psychiatr Serv (2010) 0.78
Transdiagnostic Cognitive Behavioral Therapy Versus Treatment as Usual in Adult Patients With Emotional Disorders in the Primary Care Setting (PsicAP Study): Protocol for a Randomized Controlled Trial. JMIR Res Protoc (2016) 0.77
Methods for assessing patient-clinician communication about depression in primary care: what you see depends on how you look. Health Serv Res (2014) 0.77
Affect-focused psychodynamic psychotherapy for depression and anxiety through the Internet: a randomized controlled trial. PeerJ (2013) 0.77
Salvianolic acid B ameliorates depressive-like behaviors in chronic mild stress-treated mice: involvement of the neuroinflammatory pathway. Acta Pharmacol Sin (2016) 0.77
Help-seeking for emotional problems in major depression : findings of the 2006 Estonian health survey. Community Ment Health J (2012) 0.77
Relationship between Depressive Symptoms and Cardiovascular Disease Risk Factors in African American Individuals. Depress Res Treat (2011) 0.76
Comorbidity of bipolar disorder with substance abuse: selection of prioritized genes for translational research. Summit on Translat Bioinforma (2009) 0.75
A transdiagnostic sleep and circadian treatment to improve severe mental illness outcomes in a community setting: study protocol for a randomized controlled trial. Trials (2016) 0.75
Hypothalamic gastrin-releasing peptide receptor mediates an antidepressant-like effect in a mouse model of stress. Am J Transl Res (2016) 0.75
Role of Omega-3 Fatty Acids in the Etiology, Treatment, and Prevention of Depression: Current Status and Future Directions. J Nutr Intermed Metab (2016) 0.75
The Fracture of Relational Space in Depression: Predicaments in Primary Care Help Seeking. Curr Anthropol (2016) 0.75
Inequities in access to depression treatment: results of the Brazilian National Health Survey - PNS. Int J Equity Health (2016) 0.75
An Internet-based program for depressive symptoms using human and automated support: a randomized controlled trial. Neuropsychiatr Dis Treat (2017) 0.75
Continuation rates and complications of intrauterine contraception in women diagnosed with bipolar disorder. Obstet Gynecol (2011) 0.75
The norepinephrine transporter gene is associated with the retardation symptoms of major depressive disorder in the Han Chinese population. Neural Regen Res (2012) 0.75
Therapist Training on Cognitive Behavior Therapy for Anxiety Disorders Using Internet-Based Technologies. Cognit Ther Res (2016) 0.75
Prevalence, associated factors and predictors of anxiety: a community survey in Selangor, Malaysia. BMC Psychiatry (2015) 0.75
Disparities in Treatment and Service Utilization Among Hispanics and Non-Hispanic Whites with Bipolar Disorder. J Racial Ethn Health Disparities (2016) 0.75
Longitudinal changes in somatic symptoms and family disagreements among depression and community groups: a 23-year study. BMC Psychiatry (2015) 0.75
Stigma Scale for Receiving Psychological Help (SSRPH): An Examination Among Adolescent Girls. West J Nurs Res (2014) 0.75
Neurocognitive performance as an endophenotype for mood disorder subgroups. J Affect Disord (2017) 0.75
Favorable ratings of providers' communication behaviors among U.S. women with depression: a population-based study applying the behavioral model of health services use. Womens Health Issues (2013) 0.75
Primary care clinicians' recognition and management of depression: a model of depression care in real-world primary care practice. J Gen Intern Med (2013) 0.75
Testing for clinical inertia in medication treatment of bipolar disorder. J Affect Disord (2016) 0.75
Comorbid generalized anxiety disorder and its association with quality of life in patients with major depressive disorder. Sci Rep (2017) 0.75
Use of psychotherapy in a representative adult community sample in São Paulo, Brazil. J Nerv Ment Dis (2014) 0.75
Racial-Ethnic Variation in Mental Health Service Utilization Among People with a Major Affective Disorder and a Criminal History. Community Ment Health J (2015) 0.75
Involvement of NO/cGMP pathway in the antidepressant-like effect of gabapentin in mouse forced swimming test. Naunyn Schmiedebergs Arch Pharmacol (2016) 0.75
Acute change in anterior cingulate cortex GABA, but not glutamine/glutamate, mediates antidepressant response to citalopram. Psychiatry Res (2017) 0.75
17α-ethinyl estradiol attenuates depressive-like behavior through GABAA receptor activation/nitrergic pathway blockade in ovariectomized mice. Psychopharmacology (Berl) (2016) 0.75
Rumination interacts with life stress to predict depressive symptoms: An ecological momentary assessment study. Behav Res Ther (2017) 0.75
Systematic Review and Meta-analysis of Adolescent Cognitive-Behavioral Sleep Interventions. Clin Child Fam Psychol Rev (2017) 0.75
Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry (2005) 58.92
Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry (2005) 45.33
The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA (2003) 34.83
Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA (2004) 22.38
Replicating genotype-phenotype associations. Nature (2007) 16.11
The National Comorbidity Survey Replication (NCS-R): background and aims. Int J Methods Psychiatr Res (2004) 11.14
Trends in suicide ideation, plans, gestures, and attempts in the United States, 1990-1992 to 2001-2003. JAMA (2005) 5.70
Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol (2003) 4.95
Self-management education programs in chronic disease: a systematic review and methodological critique of the literature. Arch Intern Med (2004) 4.68
Suicide risk during antidepressant treatment. Am J Psychiatry (2006) 4.41
Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst (2002) 4.16
Design and field procedures in the US National Comorbidity Survey Replication Adolescent Supplement (NCS-A). Int J Methods Psychiatr Res (2009) 3.81
Prevalence and correlates of eating disorders in adolescents. Results from the national comorbidity survey replication adolescent supplement. Arch Gen Psychiatry (2011) 3.73
The global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveys. Epidemiol Psichiatr Soc (2009) 3.55
Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable. Epidemiology (2006) 3.54
Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers. Am J Psychiatry (2006) 3.47
Individual and societal effects of mental disorders on earnings in the United States: results from the national comorbidity survey replication. Am J Psychiatry (2008) 3.45
National comorbidity survey replication adolescent supplement (NCS-A): II. Overview and design. J Am Acad Child Adolesc Psychiatry (2009) 3.31
Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients. CMAJ (2007) 3.30
Mild disorders should not be eliminated from the DSM-V. Arch Gen Psychiatry (2003) 2.88
Selective prescribing led to overestimation of the benefits of lipid-lowering drugs. J Clin Epidemiol (2006) 2.81
Screening for serious mental illness in the general population with the K6 screening scale: results from the WHO World Mental Health (WMH) survey initiative. Int J Methods Psychiatr Res (2010) 2.81
Improved comorbidity adjustment for predicting mortality in Medicare populations. Health Serv Res (2003) 2.65
Racial differences in screening for prostate cancer in the elderly. Arch Intern Med (2004) 2.34
The descriptive epidemiology of commonly occurring mental disorders in the United States. Annu Rev Public Health (2008) 2.32
Arthritis self-management education programs: a meta-analysis of the effect on pain and disability. Arthritis Rheum (2003) 2.30
Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication. Am J Psychiatry (2010) 2.30
Prevalence and age of onset for drug use in seven international sites: results from the international consortium of psychiatric epidemiology. Drug Alcohol Depend (2002) 2.16
Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Addiction (2010) 2.14
Assessing health state utilities in elderly patients at cardiovascular risk. Med Decis Making (2006) 2.12
Use and abuse of alcohol and illicit drugs in US adolescents: results of the National Comorbidity Survey-Adolescent Supplement. Arch Gen Psychiatry (2012) 2.06
Validity of the assessment of bipolar spectrum disorders in the WHO CIDI 3.0. J Affect Disord (2006) 1.99
Secondhand smoke exposure and mental health among children and adolescents. Arch Pediatr Adolesc Med (2011) 1.93
Potential causes of higher mortality in elderly users of conventional and atypical antipsychotic medications. J Am Geriatr Soc (2008) 1.84
Consistency of performance ranking of comorbidity adjustment scores in Canadian and U.S. utilization data. J Gen Intern Med (2004) 1.79
Prescription opioid use among older adults with arthritis or low back pain. Arthritis Rheum (2006) 1.77
The prevalence of psychological distress in employees and associated occupational risk factors. J Occup Environ Med (2008) 1.76
Association between SSRI use and hip fractures and the effect of residual confounding bias in claims database studies. J Clin Psychopharmacol (2004) 1.68
When is pharmacogenetic testing for antidepressant response ready for the clinic? A cost-effectiveness analysis based on data from the STAR*D study. Neuropsychopharmacology (2009) 1.65
Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis. Arthritis Rheum (2006) 1.60
Dropping out of mental health treatment: patterns and predictors among epidemiological survey respondents in the United States and Ontario. Am J Psychiatry (2002) 1.55
Rethinking mental illness. JAMA (2010) 1.53
Prevalence and correlates of prolonged fatigue in a U.S. sample of adolescents. Am J Psychiatry (2013) 1.49
Families at high and low risk for depression: a three-generation startle study. Biol Psychiatry (2005) 1.49
Understanding mental health treatment in persons without mental diagnoses: results from the National Comorbidity Survey Replication. Arch Gen Psychiatry (2007) 1.49
Dropout from outpatient mental health care in the United States. Psychiatr Serv (2009) 1.48
Associations between anxiety disorders and physical illness. Eur Arch Psychiatry Clin Neurosci (2003) 1.46
Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data. Arch Gen Psychiatry (2010) 1.43
Smoking and suicidal behaviors in the National Comorbidity Survey: Replication. J Nerv Ment Dis (2007) 1.42
Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts. Pediatrics (2010) 1.40
Latent class and genetic analysis does not support migraine with aura and migraine without aura as separate entities. Genet Epidemiol (2004) 1.39
Medicaid's prior authorization program and access to atypical antipsychotic medications. Health Aff (Millwood) (2007) 1.38
Mental and physical comorbid conditions and days in role among persons with arthritis. Psychosom Med (2006) 1.34
The STAR*D trial: revealing the need for better treatments. Psychiatr Serv (2009) 1.33
Are sleep difficulties associated with migraine attributable to anxiety and depression? Headache (2008) 1.32
Headache in a national sample of American children: prevalence and comorbidity. J Child Neurol (2009) 1.30
Socio-demographic risk factors for alcohol and drug dependence: the 10-year follow-up of the national comorbidity survey. Addiction (2009) 1.29
Association between morningness-eveningness and behavioral/emotional problems among adolescents. J Biol Rhythms (2007) 1.27
Identification of hospitalizations for intentional self-harm when E-codes are incompletely recorded. Pharmacoepidemiol Drug Saf (2010) 1.26
Episodic migraine and obesity and the influence of age, race, and sex. Neurology (2013) 1.24
Sociodemographic predictors of transitions across stages of alcohol use, disorders, and remission in the National Comorbidity Survey Replication. Compr Psychiatry (2008) 1.24
Differentiating nonrestorative sleep from nocturnal insomnia symptoms: demographic, clinical, inflammatory, and functional correlates. Sleep (2013) 1.21
Evaluating the validity of an instrumental variable study of neuroleptics: can between-physician differences in prescribing patterns be used to estimate treatment effects? Med Care (2007) 1.21
Do Canada and the United States differ in prevalence of depression and utilization of services? Psychiatr Serv (2007) 1.17
Prevalence of mental disorders in the Zurich Cohort Study: a twenty year prospective study. Epidemiol Psichiatr Soc (2005) 1.16
The association between mood and anxiety disorders with vascular diseases and risk factors in a nationally representative sample. J Psychosom Res (2010) 1.13
Acute exposure to stress improves performance in trace eyeblink conditioning and spatial learning tasks in healthy men. Learn Mem (2007) 1.10
Lipid levels and bone mineral density. Am J Med (2005) 1.09
The psychosis spectrum in a young U.S. community sample: findings from the Philadelphia Neurodevelopmental Cohort. World Psychiatry (2014) 1.07
Transition to schizophrenia and related disorders: toward a taxonomy of risk. Schizophr Bull (2003) 1.05
Genomewide significant linkage to migrainous headache on chromosome 5q21. Am J Hum Genet (2005) 1.04
The Strengths and Difficulties Questionnaire (SDQ): the factor structure and scale validation in U.S. adolescents. J Abnorm Child Psychol (2013) 1.04
Attention deficit hyperactivity disorder: concordance of the adolescent version of the Composite International Diagnostic Interview Version 3.0 (CIDI) with the K-SADS in the US National Comorbidity Survey Replication Adolescent (NCS-A) supplement. Int J Methods Psychiatr Res (2010) 1.03
Assessing residual confounding of the association between antipsychotic medications and risk of death using survey data. CNS Drugs (2009) 1.02
Social phobia and subtypes in the national comorbidity survey-adolescent supplement: prevalence, correlates, and comorbidity. J Am Acad Child Adolesc Psychiatry (2011) 1.01
Claims data studies of sedative-hypnotics and hip fractures in older people: exploring residual confounding using survey information. J Am Geriatr Soc (2005) 1.00
The use of genetic epidemiology to guide classification in child and adult psychopathology. Int Rev Psychiatry (2007) 0.99
Instrumental variable analysis of secondary pharmacoepidemiologic data. Epidemiology (2006) 0.97
Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes. Am J Kidney Dis (2005) 0.97
Post-traumatic stress disorder, drug abuse and migraine: new findings from the National Comorbidity Survey Replication (NCS-R). Cephalalgia (2010) 0.97
Clinical differences among patients treated for mental health problems in general medical and specialty mental health settings in the National Comorbidity Survey Replication. Gen Hosp Psychiatry (2006) 0.96
Reappraisal of the interplay between psychosis and depression symptoms in the pathogenesis of psychotic syndromes: results from a twenty-year prospective community study. Eur Arch Psychiatry Clin Neurosci (2010) 0.96
Ventricular arrhythmias and cerebrovascular events in the elderly using conventional and atypical antipsychotic medications. J Clin Psychopharmacol (2007) 0.95
Low socioeconomic status and mental health care use among respondents with anxiety and depression in the NCS-R. Psychiatr Serv (2009) 0.95
Improving targets for the prevention of drug use disorders: sociodemographic predictors of transitions across drug use stages in the national comorbidity survey replication. Prev Med (2008) 0.95
Toward enough of the best for all: research to transform the efficacy, quality, and reach of mental health care for youth. Adm Policy Ment Health (2010) 0.94
Physical comorbidity of migraine and other headaches in US adolescents. J Pediatr (2012) 0.94
Maximizing efficiency and impact in effectiveness and services research. Gen Hosp Psychiatry (2010) 0.93
Distinguishing generalized anxiety disorder from major depression: prevalence and impairment from current pure and comorbid disorders in the US and Ontario. Int J Methods Psychiatr Res (2002) 0.92
Structure of major depressive disorder in adolescents and adults in the US general population. Br J Psychiatry (2012) 0.92
The prevalence and correlates of workplace depression in the national comorbidity survey replication. J Occup Environ Med (2008) 0.92
Delay of first treatment of mental and substance use disorders in Mexico. Am J Public Health (2007) 0.91
Treatment and adequacy of treatment of mental disorders among respondents to the Mexico National Comorbidity Survey. Am J Psychiatry (2006) 0.91